← Back to Search

Baseline Opioid for Chronic Pain

Phase 2
Waitlist Available
Led By Kendric B Speagle, BA
Research Sponsored by Daisy Pharma Opioid Venture, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study visits 1-5 (days 1, 14, 28, 56, 82)
Awards & highlights

Study Summary

This trial will study if Dronabinol, when taken with opioid painkillers, can reduce pain and opioid side effects. Participants take the study drug and their regular opioids and results are evaluated.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study visits 1-5 (days 1, 14, 28, 56, 82)
This trial's timeline: 3 weeks for screening, Varies for treatment, and study visits 1-5 (days 1, 14, 28, 56, 82) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain Intensity Scale (0-10)
Self-Reported Opioid Use (Opioid Dose)
Self-Reported Opioid Use Frequency (Opioid Dose Frequency)
Secondary outcome measures
Bowel Function Inventory-Revised (BFI-R)
Brief Pain Inventory (BPI)
Current Opioid Misuse Measure (COMM)
+13 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Baseline OpioidExperimental Treatment1 Intervention
One of Seven existing Baseline Opioid subgroups (Hydrocodone, Oxycodone, Morphine, Hydromorphone, Buprenorphine, Tramadol) coadministered with intervention drug, Dronabinol.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dronabinol
FDA approved

Find a Location

Who is running the clinical trial?

Daisy Pharma Opioid Venture, LLCLead Sponsor
Kendric B Speagle, BAPrincipal InvestigatorDaisy Research

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Dronabinol Opioid Sparing Evaluation (DOSE) Trial
2018. "Dronabinol Opioid Sparing Evaluation (DOSE) Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03766269.
All > Cannabis
~44 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top